Steve Weitman, M.D., Ph.D., is the director of the Institute for Drug Development at the CTRC. Prior to joining the IDD in 2011, he was a full-time consultant to academic organizations and industry focused on bringing new anticancer therapies to patients. Dr. Weitman also served as chief medical officer and senior vice president at ILEX Oncology. He is a pediatric oncologist who works on the development of new therapies for both adult and pediatric patients. In returning to the Health Science Center, where from 1996 to 2001 he was a program director within the IDD, his goal is to create and support oncology drug development, build experimental clinical (phase I and phase II) programs and develop individualized patient cancer treatment initiatives involving both laboratory and clinical teams.